₹ 50.13
-2.63 (-4.98%)
BSE
G
Genomic Valley Biotech
₹ 50.13
BSE
GVBL Financials Summary
Genomic Valley Biotech revenue stood at ₹0 Cr in Sep 2026 versus nil in the previous quarter, while net profit stood at ₹0 Cr versus nil in the previous quarter. Compared to the same quarter last year, revenue is down 100.00% and net profit stood at ₹0 Cr versus nil a year ago. EPS for the quarter stood at -₹0.06, decreased from ₹0.05 in the previous quarter and down from ₹0.01 a year ago.
Genomic Valley Biotech Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Get In-depth View of GVBL Quaterly Results, Balance Sheet, Cashflows & Corporate Action.
GVBL Revenue Growth
All values are in Crores
Revenue
Profit
Loss

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






